Q4 2023 Holdings
Filed 2024-02-07 | 47 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | Common | 834203309 | $338.8M | 8,418,093 | 27.7% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $95.8M | 9,546,485 | 7.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $84.5M | 4,249,918 | 6.9% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $84.2M | 2,606,247 | 6.9% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $62.8M | 4,220,048 | 5.1% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $57.8M | 4,096,428 | 4.7% |
| Geron Corp(GERN) | Common | 374163103 | $50.9M | 24,143,681 | 4.2% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $43.2M | 6,657,992 | 3.5% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $36.6M | 1,678,207 | 3.0% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $36.1M | 1,784,006 | 3.0% |
| Icosavax, Inc. | Common | 45114M109 | $26.9M | 1,704,568 | 2.2% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $26.3M | 1,873,704 | 2.2% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $19.1M | 2,482,727 | 1.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | Common | 02083G100 | $15.6M | 819,275 | 1.3% |
| Tourmaline Bio Inc.(TRML) | Common | 89157D105 | $15.5M | 591,882 | 1.3% |
| Compass Pathway PLC(CMPS) | SPONSORED ADS | 20451W101 | $14.1M | 1,608,000 | 1.2% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $13.8M | 1,035,136 | 1.1% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $13.2M | 2,244,941 | 1.1% |
| Verastem Inc(VSTM) | Common | 92337C203 | $12.5M | 1,538,461 | 1.0% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $12.5M | 350,000 | 1.0% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $11.6M | 6,173,439 | 1.0% |
| Zai Lab Ltd(ZLAB) | ADR | 98887Q104 | $11.3M | 411,677 | 0.9% |
| Apogee Therapeutics Inc(APGE) | Common | 03770N101 | $11.2M | 400,000 | 0.9% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $10.5M | 856,008 | 0.9% |
| Genetron Holdings Ltd | ADS | 37186H209 | $10.0M | 2,708,056 | 0.8% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $9.9M | 1,650,440 | 0.8% |
| Savara Inc(SVRA) | Common | 805111101 | $9.8M | 2,088,323 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.9M | 510,204 | 0.7% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $8.2M | 2,988,000 | 0.7% |
| Pharvaris NV(PHVS) | Common | N69605108 | $8.0M | 285,000 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | Common | 68622P109 | $7.8M | 849,681 | 0.6% |
| Rayzebio Inc | Common | 75525N107 | $6.9M | 110,581 | 0.6% |
| Engene Holdings Inc.(ENGN) | Common | 29286M105 | $6.3M | 678,705 | 0.5% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $5.5M | 3,556,023 | 0.5% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $5.3M | 655,057 | 0.4% |
| Instil Bio Inc(TIL) | Common | 45783C200 | $4.8M | 624,340 | 0.4% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $4.2M | 137,411 | 0.3% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $3.9M | 3,521,291 | 0.3% |
| Delcath Systems, Inc.(DCTH) | Common | 24661P807 | $3.6M | 855,191 | 0.3% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $3.2M | 3,242,842 | 0.3% |
| Unicycive Therapeutics | Common | 90466Y103 | $3.0M | 3,470,152 | 0.2% |
| DBV Technologies SA | SPONSORED ADS | 23306J101 | $2.6M | 2,708,875 | 0.2% |
| Aligos Therapeutics Inc | Common | 01626L105 | $2.4M | 3,547,030 | 0.2% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.2M | 388,144 | 0.1% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $1.0M | 509,572 | 0.1% |
| Homology Medicines, Inc. | Common | 438083107 | $225.0K | 370,068 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $51.2K | 140,255 | 0.0% |